newsfilter
← Latest News
ACCESS Newswire·

XPhyto Provides Update on Drug Formulation and Development Business

Rotigotine transdermal human pilot study successfully completed; program advancing to pivotal study Land purchased for construction of commercial drug manufacturing facility in Germany VANCOUVER, BC & BIBERACH, GERMANY / ACCESSWIRE / May 13, 2021 / X